Recent advances in the neuroimaging of multiple sclerosis

William Rooney, Patricia K. Coyle

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Neuroimaging studies continue to provide important insights into the central nervous system disease pathology of multiple sclerosis (MS). Although conventional magnetic resonance imaging remains the mainstay of diagnosis and laboratory assessment of therapeutic response in MS, quantitative techniques continue to extend our understanding of both macroscopic and microscopic disease processes. Over the past year, many published studies have investigated measures of brain atrophy, gray matter involvement, vascular properties, and myelin and neuronal loss and have examined their relationship to clinical disease expression, genotype, and therapy. An important trend continuing over the past year is the development of targeted agents to improve the pathologic specificity of imaging measures. Specific disease measures such as endothelial activation, microglial activation, and cell trafficking are accessible to neuroimaging and offer significant promise for improved characterization of central nervous system involvement in MS.

Original languageEnglish (US)
Pages (from-to)217-224
Number of pages8
JournalCurrent Neurology and Neuroscience Reports
Volume5
Issue number3
StatePublished - May 2005
Externally publishedYes

Fingerprint

Neuroimaging
Multiple Sclerosis
Clinical Laboratory Techniques
Central Nervous System Diseases
Myelin Sheath
Atrophy
Blood Vessels
Central Nervous System
Genotype
Magnetic Resonance Imaging
Pathology
Brain
Therapeutics
Gray Matter

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Recent advances in the neuroimaging of multiple sclerosis. / Rooney, William; Coyle, Patricia K.

In: Current Neurology and Neuroscience Reports, Vol. 5, No. 3, 05.2005, p. 217-224.

Research output: Contribution to journalArticle

@article{4638b78b9b544286b8f6a3209d8a45ff,
title = "Recent advances in the neuroimaging of multiple sclerosis",
abstract = "Neuroimaging studies continue to provide important insights into the central nervous system disease pathology of multiple sclerosis (MS). Although conventional magnetic resonance imaging remains the mainstay of diagnosis and laboratory assessment of therapeutic response in MS, quantitative techniques continue to extend our understanding of both macroscopic and microscopic disease processes. Over the past year, many published studies have investigated measures of brain atrophy, gray matter involvement, vascular properties, and myelin and neuronal loss and have examined their relationship to clinical disease expression, genotype, and therapy. An important trend continuing over the past year is the development of targeted agents to improve the pathologic specificity of imaging measures. Specific disease measures such as endothelial activation, microglial activation, and cell trafficking are accessible to neuroimaging and offer significant promise for improved characterization of central nervous system involvement in MS.",
author = "William Rooney and Coyle, {Patricia K.}",
year = "2005",
month = "5",
language = "English (US)",
volume = "5",
pages = "217--224",
journal = "Current Neurology and Neuroscience Reports",
issn = "1528-4042",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Recent advances in the neuroimaging of multiple sclerosis

AU - Rooney, William

AU - Coyle, Patricia K.

PY - 2005/5

Y1 - 2005/5

N2 - Neuroimaging studies continue to provide important insights into the central nervous system disease pathology of multiple sclerosis (MS). Although conventional magnetic resonance imaging remains the mainstay of diagnosis and laboratory assessment of therapeutic response in MS, quantitative techniques continue to extend our understanding of both macroscopic and microscopic disease processes. Over the past year, many published studies have investigated measures of brain atrophy, gray matter involvement, vascular properties, and myelin and neuronal loss and have examined their relationship to clinical disease expression, genotype, and therapy. An important trend continuing over the past year is the development of targeted agents to improve the pathologic specificity of imaging measures. Specific disease measures such as endothelial activation, microglial activation, and cell trafficking are accessible to neuroimaging and offer significant promise for improved characterization of central nervous system involvement in MS.

AB - Neuroimaging studies continue to provide important insights into the central nervous system disease pathology of multiple sclerosis (MS). Although conventional magnetic resonance imaging remains the mainstay of diagnosis and laboratory assessment of therapeutic response in MS, quantitative techniques continue to extend our understanding of both macroscopic and microscopic disease processes. Over the past year, many published studies have investigated measures of brain atrophy, gray matter involvement, vascular properties, and myelin and neuronal loss and have examined their relationship to clinical disease expression, genotype, and therapy. An important trend continuing over the past year is the development of targeted agents to improve the pathologic specificity of imaging measures. Specific disease measures such as endothelial activation, microglial activation, and cell trafficking are accessible to neuroimaging and offer significant promise for improved characterization of central nervous system involvement in MS.

UR - http://www.scopus.com/inward/record.url?scp=21044431931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21044431931&partnerID=8YFLogxK

M3 - Article

C2 - 15865887

AN - SCOPUS:21044431931

VL - 5

SP - 217

EP - 224

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 3

ER -